liberDi is an innovative all-in-one portable Digital Dialysis Clinic providing scalable, digital and safe, self-care anywhere. It provides an Intelligent Dialysis Assistant (IDA) and remote medical supervision, allowing patients to choose Anywhere PD (Peritoneal Dialysis) as first modality.
liberDi’s system is positioned to replace traditional full-service, in-clinic care with a self-care system suitable for many dialysis patients. Focused on patient care liberation and improved quality of life, liberDi allows many more people requiring dialysis to do so easily and comfortably from their home, office or on vacation.
liberDi received FDA clearance in December 2022.
Worldwide 3.2 million people suffer from end-stage renal disease. This number continues to grow due to an aging population and the increase of conditions such as diabetes, hypertension, and obesity. The market seeks an effective, easy-to-use dialysis solution for improved treatment benefits and reduced health care costs.
Globally, there is a gradual shift toward home-based dialysis therapies. This shift is attributed to (1) increasing costs associated with in-center hemodialysis (equipment, staff, and procedure-related clinical complications) and (2) clinical evidence demonstrating the value of peritoneal dialysis (PD) in improving quality of life.